Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin versus aspirin + Osvix after coronary artery bypass grafting
IRCT20141209020258N157Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- May 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronary arteriosclerosis comparing Aspirin with Aspirin + Osvix (2 arms). Primary endpoints: Incidence of myocardial infarction, Bleeding and 3 more. Started May 2021; status: completed.
02
Drugs
aspirinclopidogrel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20141209020258N157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N157.